Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 9

    Merck gets Japanese nod for TEPMETKO(tepotinib) for non-small cell lung cancer

    Merck gets Japanese nod for TEPMETKO(tepotinib) for non-small cell lung cancer

    Medical Dialogues Bureau28 March 2020 11:45 AM IST
    TEPMETKO is the first regulatory approval globally for an oral MET inhibitor indicated for the treatment of advanced NSCLC harboring MET gene...
    Genentech,BARDA gets USFDA nod for Actemra Clinical Trial in COVID-19 patients

    Genentech,BARDA gets USFDA nod for Actemra Clinical Trial in COVID-19 patients

    Medical Dialogues Bureau28 March 2020 10:15 AM IST
    US: Genentech, a member of the Roche Group has announced the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind,...
    100 distilleries and more than 500 manufacturers permitted to produce hand sanitizers by Government

    100 distilleries and more than 500 manufacturers permitted to produce hand sanitizers by Government

    Medical Dialogues Bureau27 March 2020 1:35 PM IST
    Delhi: Central and State Governments are taking all steps to ensure the supply of essential items during the lockdown to combat the novel Coronavirus....
    Caplin Steriles gets USFDA approval for Verapamil Hydrochloride Injection

    Caplin Steriles gets USFDA approval for Verapamil Hydrochloride Injection

    Medical Dialogues Bureau27 March 2020 1:11 PM IST
    Verapamil Hydrochloride is a calcium channel blocker used in the treatment of cardiac conditions such as high blood pressure, arrhythmias, and angina.
    Hydroxychloroquine now a Prescription Drug: Health Ministry gazette puts it in Schedule H1 of DCA

    Hydroxychloroquine now a Prescription Drug: Health Ministry gazette puts it in Schedule H1 of DCA

    Medical Dialogues Bureau27 March 2020 1:07 PM IST
    New Delhi: Soon after banning the export of the Drug Hydroxychloroquine in light of the coronavirus, the government has now made the Drug into a...
    Cipla gets USFDA final nod for Esomeprazole ANDA for Oral Suspension

    Cipla gets USFDA final nod for Esomeprazole ANDA for Oral Suspension

    Medical Dialogues Bureau27 March 2020 12:51 PM IST
    Cipla's Esomeprazole for Oral Suspension 10mg, 20mg and 40mg is an AB-rated generic therapeutic equivalent version of AstraZeneca Pharmaceutical's ...
    Strides Pharma gets USFDA EIR for its Bangalore flagship facility

    Strides Pharma gets USFDA EIR for its Bangalore flagship facility

    Medical Dialogues Bureau27 March 2020 11:26 AM IST
    Bangalore: Strides Pharma has announced that the Company's flagship facility (KRS Gardens) in Bangalore which was inspected by the USFDA in March...
    Lupin appoints Ramesh Swaminathan as CFO, Head Corporate Affairs

    Lupin appoints Ramesh Swaminathan as CFO, Head Corporate Affairs

    Medical Dialogues Bureau27 March 2020 9:30 AM IST
    Mumbai: Pharma Major Lupin Limited (Lupin) announced the appointment of Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs....
    Mylab ships first batch of COVID-19 test kits to government and private labs

    Mylab ships first batch of COVID-19 test kits to government and private labs

    Medical Dialogues Bureau26 March 2020 2:33 PM IST
    Pune: Pune-based molecular diagnostics company Mylab Discovery Solutions Pvt Ltd the developed first Made in India Covid-19 testing kit.Mylab has...
    Shortage of API: Bengal Chemicals can only supply only 10 lakh hydroxy-chloroquine

    Shortage of API: Bengal Chemicals can only supply only 10 lakh hydroxy-chloroquine

    Medical Dialogues Bureau26 March 2020 1:14 PM IST
    Kolkata: PSU pharma company Bengal Chemicals and Pharmaceuticals Ltd (BPCL) on Tuesday said it can provide only a maximum of 10 lakh...
    Beware of fake COVID-19 cyber cures warns EU medicines agency

    Beware of fake COVID-19 cyber cures warns EU medicines agency

    Medical Dialogues Bureau26 March 2020 12:29 PM IST
    The Hague: Europe's medicines agency Tuesday warned consumers not to buy any online medication claiming to be a treatment for COVID-19, saying doing...
    BAN on export of anti-malarial drug hydroxycloroquine with immediate effect: Govt

    BAN on export of anti-malarial drug hydroxycloroquine with immediate effect: Govt

    Medical Dialogues Bureau26 March 2020 12:27 PM IST
    "The export of hydroxycloroquine and formulations made from hydroxycloroquine is prohibited with immediate effect".
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok